Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial

INTRODUCTION: Strong centrally acting analgesics, including tapentadol prolonged release (PR), have demonstrated efficacy for the management of non-malignant, chronic pain. Maintaining patient independence, including the ability to drive safely, is a key goal of long-term analgesic therapy. This mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatowski, Rainer, Scharnagel, Rüdiger, Gyllensvärd, Anne, Steigerwald, Ilona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108021/
https://www.ncbi.nlm.nih.gov/pubmed/25135385
http://dx.doi.org/10.1007/s40122-014-0025-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108021/
https://www.ncbi.nlm.nih.gov/pubmed/25135385
http://dx.doi.org/10.1007/s40122-014-0025-3

Ejemplares similares